Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Infertility 1Anovulation 1

Interventions

Metformin 14Clomiphene 6Progesterone 5Chorionic Gonadotropin 5drospirenone and ethinyl estradiol combination 4Sugars 4Letrozole 4Flutamide 4Estrogens 4Cholecalciferol 4follitropin alfa 3Pioglitazone 3Medroxyprogesterone Acetate 3Glycoprotein Hormones, alpha Subunit 3Estradiol 3Vitamin D 2Testosterone 2Resistance Training 2Raloxifene Hydrochloride 2Ovidrel 2Liraglutide 2Leuprolide 2Glucose Tolerance Test 2Exenatide 2Ethinyl Estradiol 2Contraceptives, Oral 2Continuous Positive Airway Pressure 2saxagliptin 1salicylsalicylic acid 1penclomedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Polycystic Ovary Syndrome × Glycoprotein Hormones, alpha Subunit × Clear all
NCT01653743 2016-01-07

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
81 enrolled 11 charts

Anovulation, Polycystic Ovary Syndrome

NCT01081626 2014-02-13

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Merck KGaA, Darmstadt, Germany

Phase 4 Completed
310 enrolled 18 charts

Infertility, Polycystic Ovary Syndrome

NCT01185704 2014-02-13

ATTAC-PCO

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
136 enrolled 21 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡